Rheumatology

Your Article Summary

See Latest Articles

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09

Giardina AR et al. – The efficacy and safety of both etanercept and infliximab in patients with ankylosing spondylitis were compared in a 2–year open label randomised study. The results are consistent with a significant more rapid clinical improvement in the infliximab treated group. Treatment with both etanercept and infliximab at the end of the study was effective, safe, and well tolerated.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09

Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

See All of Clinical Pharmacology

Today in Spondylarthropathies...keeping you current

Receive free subspecialty "5-minute updates" via email

Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09

Agreement between quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis
Journal of Rheumatology, 11/18/09

Recreational Exercise in Rheumatic Diseases
International Journal of Sports Medicine, 10/30/09

See All of Spondylarthropathies